ADS Diagnostic Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from ADS Diagnostic Ltd. on BSE

Search Inside the pdf :

30 May 2025

Company Update

A D S Diagnostics Ltd - 523031 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Regulation 24(A) of SEBI LODR REGULATIONS 2015, Please find attached herewith Annual secretarial Compliance report for the year ended 31st March,2025.

pdf

ADS Diagnostic Ltd.

30 May 2025

Company Update

A D S Diagnostics Ltd - 523031 - Board Meeting Outcome for Revised Outcome

BSE India

Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform you that the Board of Directors (the ''Board'') of ADS Diagnostic Limited (''the Company'') at its meeting held today i.e. Friday 30th May,2025 considered and approved the audited financial results of the company and limited review report issued by Statutory Auditors of the company M/s. V.N. Purohit & Co. Chartered Accountants, for the year ended 31st March,2025. The Board has recommended a Dividend @ 10% per share i.e. Rs.1 Per Share /- (Rupees One only) per Equity Share of face value of Rs. 10/- each fully paid-up for the Financial Year 2024-25, subject to approval of shareholders of the Company. The Board Meeting commenced at 11:30 a.m. and concluded at 02:25 p.m.

pdf

ADS Diagnostic Ltd.

30 May 2025

Board Meeting

A D S Diagnostics Ltd - 523031 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

pdf

ADS Diagnostic Ltd.

20 May 2025

Company Update

A D S Diagnostics Ltd - 523031 - Disclosures Made Under Regulation 31(4) Of SEBI (Substantial …

BSE India

Disclosure made under regulation 31(4) of SEBI LORD Regulation

pdf

ADS Diagnostic Ltd.

20 May 2025

Board Meeting

A D S Diagnostics Ltd - 523031 - Board Meeting Intimation for Notice Of Board Meeting …

BSE India

A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, 30th May, 2025 at the Registered Office of the Company, to inter alia transact the following business. 1. To consider and approve Audited Financial Results of the Company for the quarter ended 31st March, 2025. 2. To consider and transit any other businesses, if any, which may be placed before the Board with the permission of the Chairman

pdf

ADS Diagnostic Ltd.

16 Apr 2025

Company Update

A D S Diagnostics Ltd - 523031 - Compliance Under Regulation 6(1) And 7(1)

BSE India

COMPLIANCE UNDER REGULATION 6(1) AND 7(1) OF SEBI LODR

pdf

ADS Diagnostic Ltd.

16 Apr 2025

Company Update

A D S Diagnostics Ltd - 523031 - Compliance Certificate Pursuant To Regulation 40(9) Of SEBI …

BSE India

COMPLIANCE CERTIFICATE PURSUANT TO REGULATION 40(9) OF SEBI LODR REGULATIONS 2015

pdf

ADS Diagnostic Ltd.

03 Mar 2025

Corp. Note

ADS DIAGNOSTIC LTD. - 523031 - Integrated Filing (Financial)

BSE India

unaudited result december2024

pdf

ADS Diagnostic Ltd.

07 Feb 2025

Board Meeting

ADS DIAGNOSTIC LTD. - 523031 - Board Meeting Outcome for Compliance As Per Regulation 33 Of …

BSE India

Please find herewith a copy of the approved unaudited financial results of the company and limited review report issued by M/s. V.N. Purohit & Co. Chartered Accountants and Statutory Auditors of the company for the quarter ended 31st December, 2024 approved in its meeting of the board of directors dated 07.02.2025.

pdf

ADS Diagnostic Ltd.

30 Jan 2025

Board Meeting

ADS DIAGNOSTIC LTD. - 523031 - Board Meeting Intimation for Notice Of Board Meeting Of The …

BSE India

ADS DIAGNOSTIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 ,inter alia, to consider and approve Pursuant to Regulation 29, 30, 33 & 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (hereinafter referred to as 'the Listing Regulations, 2015'), it is hereby informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 7th, 2025 at 11.30 A.M via Video Conferencing inter alia to consider, approve and take on record the following matters: 1. Unaudited Standalone & Consolidated Financial Results together with its Limited Review Report for the Quarter and Nine Months ended on December 31, 2024. 2. Any other matter with the permission of the Chairperson.

pdf

Is ADS Diagnostic Ltd. worth buying?

3 Votes:

Buy 66.67%

Hold 33.33%